Authors: BAGDASARIAN A TONETTA S HAREL W MAMIDI R UEMURA Y

Citation: A. Bagdasarian et al., IVIG ADVERSE REACTION - POTENTIAL ROLE OF CYTOKINES AND VASOACTIVE SUBSTANCES, Vox sanguinis, 74(2), 1998, pp. 74-82

Authors: HAREL W HERRING S MCKELVEY T MAMIDI R

Citation: W. Harel et al., EFFECT OF FACTOR-IX PREPARATIONS OF DIFFERENT PURITY ON CELL-PROLIFERATION, Blood, 86(10), 1995, pp. 3479-3479

Authors: MITCHELL MS JAKOWATZ J HAREL W DEAN G STEVENSON L BOSWELL WD GROSHEN S

Citation: Ms. Mitchell et al., INCREASED EFFECTIVENESS OF INTERFERON ALFA-2B FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY FOR MELANOMA, Journal of clinical oncology, 12(2), 1994, pp. 402-411

Authors: KANMITCHELL J HUANG XQ STEINMAN L OKSENBERG JR HAREL W PARKER JW GOEDEGEBUURE PS DARROW TL MITCHELL MS

Citation: J. Kanmitchell et al., CLONAL ANALYSIS OF INVIVO ACTIVATED CD8-LYMPHOCYTES FROM A MELANOMA PATIENT RESPONSIVE TO ACTIVE SPECIFIC IMMUNOTHERAPY( CYTOTOXIC T), Cancer immunology and immunotherapy, 37(1), 1993, pp. 15-25

Authors: HAREL W MCKELVEY T MAMIDI R UEMURA Y

Citation: W. Harel et al., INTRAVENOUS IMMUNOGLOBULIN-G (IGIV) PREPARATIONS CONTAIN HIGH-TITER ANTIBODIES TO BACTERIAL EXOTOXIN SUPERANTIGENS, The Journal of immunology, 150(8), 1993, pp. 233-233

Authors: HAREL W MCKELVEY T MAMIDI R BHATTACHARYA P UEMURA Y

Citation: W. Harel et al., LACK OF INHIBITORY EFFECTS ON CELL-PROLIFERATION BY HIGH-PURITY COAGULATION FACTOR-VIII CONCENTRATES, Blood, 82(10), 1993, pp. 10000062-10000062